pentolinium tartrate has been researched along with Parkinsonian Disorders in 1 studies
Pentolinium Tartrate: A nicotinic antagonist that has been used as a ganglionic blocking agent in hypertension.
pentolinium tartrate : The bitartrate salt of pentolinium.
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| PEASTON, MJ | 1 |
1 other study available for pentolinium tartrate and Parkinsonian Disorders
| Article | Year |
|---|---|
PARKINSONISM ASSOCIATED WITH ALPHA-METHYLDOPA THERAPY.
Topics: Antihypertensive Agents; Brain Diseases; Humans; Methyldopa; Parkinsonian Disorders; Pempidine; Pent | 1964 |